EQT AB and KKR & Co. are among several buyout firms weighing bids for German health-care technology provider Stratec SE, according to people familiar with the matter.
CVC Capital Partners and Permira are also exploring offers, the people said, asking not to be identified discussing confidential information. The private equity firms have expressed preliminary interest in a stake being sold by Stratec’s founder Hermann Leistner and his family, the people said.
A move for Leistner’s 40.55% holding could trigger a bid for all of Frankfurt-listed Stratec, which has a market value of 1.2 billion euros ($1.4 billion). Bloomberg News reported in February that Leistner was exploring options for the company.
Read more: BNN Bloomberg
